Helen Sanders
Overview
Explore the profile of Helen Sanders including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
199
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jenkin D, Makinson R, Sanders H, Sampson A, Platt A, Tran N, et al.
Lancet Microbe
. 2025 Feb;
:101022.
PMID: 39922207
Background: Four Orthoebolavirus species can cause Ebola disease, with Ebola virus (species Orthoebolavirus zairense) and Sudan virus (species Orthoebolavirus sudanense) responsible for the majority of outbreaks and cases. No vaccines...
2.
Borsier E, Sanders H, Taylor G
R Soc Open Sci
. 2024 Aug;
11(6):240007.
PMID: 39100151
Flying animals have had to evolve robust and effective guidance strategies for dealing with habitat clutter. Birds and insects use optic flow expansion cues to sense and avoid obstacles, but...
3.
Voysey M, Flaxman A, Aboagye J, Aley P, Belij-Rammerstorfer S, Bibi S, et al.
Clin Exp Immunol
. 2023 Feb;
211(3):280-287.
PMID: 36729167
The trajectory of immune responses following the primary dose series determines the decline in vaccine effectiveness over time. Here we report on maintenance of immune responses during the year following...
4.
Fidler S, Fox J, Tipoe T, Longet S, Tipton T, Abeywickrema M, et al.
Clin Infect Dis
. 2022 Oct;
76(2):201-209.
PMID: 36196614
Background: People with human immunodeficiency virus (HIV) on antiretroviral therapy (ART) with good CD4 T-cell counts make effective immune responses following vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)....
5.
Jenkin D, Ritchie A, Aboagye J, Fedosyuk S, Thorley L, Provstgaad-Morys S, et al.
Lancet Microbe
. 2022 Jul;
3(9):e663-e671.
PMID: 35907430
Background: Rabies kills around 60 000 people each year. ChAdOx2 RabG, a simian adenovirus-vectored rabies vaccine candidate, might have potential to provide low-cost single-dose pre-exposure rabies prophylaxis. This first-in-human study...
6.
Alkhouri N, Sanders H, Waite C, Marshman Z, Ashley P
Br Dent J
. 2022 Jul;
PMID: 35790813
Introduction Dental general anaesthetic (DGA) remains one of the main modalities to deliver treatment to paediatric patients. The main central registry system which is used as a proxy measure of...
7.
Ogbe A, Pace M, Bittaye M, Tipoe T, Adele S, Alagaratnam J, et al.
JCI Insight
. 2022 Feb;
7(7).
PMID: 35192543
Duration of protection from SARS-CoV-2 infection in people living with HIV (PWH) following vaccination is unclear. In a substudy of the phase II/III the COV002 trial (NCT04400838), 54 HIV+ male...
8.
Flaxman A, Marchevsky N, Jenkin D, Aboagye J, Aley P, Angus B, et al.
Lancet
. 2021 Sep;
398(10304):981-990.
PMID: 34480858
Background: COVID-19 vaccine supply shortages are causing concerns about compromised immunity in some countries as the interval between the first and second dose becomes longer. Conversely, countries with no supply...